GrantRegister

Federal Agency · National Institutes of Health

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

Last updated: July 27, 2026

Posted December 30, 2024

Funding

Up to $150K

Closes

August 11, 2027

NAICS

541714

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.

Program Details

National Institutes of Health is a federal agency that offers the Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) grant program to support rd grants. This funding opportunity is available nationally and is administered by National Institutes of Health through Grants.gov. Organizations seeking funding for rd grants should review the details below and confirm their eligibility before preparing an application.

Eligibility

Eligible applicants include tribal governments and Native American organizations, government agencies and municipalities, for-profit businesses, and eligible organizations. Organizations that meet the eligibility criteria are encouraged to apply and to review the full program guidelines before submission. Because eligibility rules and funding priorities can change between cycles, applicants should always confirm the current requirements with National Institutes of Health or on Grants.gov before investing time in an application.

Funding and Timeline

Funding available: Up to $150K. The application deadline is August 11, 2027 (379 days remaining). Applicants should allow sufficient time to gather required documentation, including organizational information, project descriptions, budgets, and supporting materials as specified in the program guidelines. Submitting a complete application well ahead of the deadline reduces the risk of disqualification on technical or administrative grounds.

Program Focus

This grant supports rd grants. This grant is associated with NAICS industry classifications: 541714, 621111, 621112, 622, 541715. Organizations operating in these sectors are encouraged to review eligibility. Funded projects are expected to demonstrate measurable outcomes aligned with the program's stated objectives. Grant recipients may be required to submit progress reports and final evaluations as a condition of the award, and to retain records for audit and compliance purposes.

How to Apply

Eligible organizations can apply through Grants.gov. Create a free organization profile on GrantRegister to see whether this grant matches your organization's NAICS code, entity type, location, and focus area, and to receive a weekly digest of every open grant you qualify for.

GrantRegister maintains a complete, authoritative registry of US federal, state, and foundation grant opportunities — matched automatically to your organization profile and delivered every Monday.

Eligibility

  • Funded by NIH
  • Programs related to basic research

Award details

Award range: Up to $150K. Applications close on August 11, 2027 (379 days remaining).

Categories

Rd Grants

Sign up at GrantRegister to see if this grant matches your organization.

Match my organization →

View application on Grants.gov·Source: Grants.gov·Last seen Jul 27, 2026

Similar grants